Vivos Therapeutics Appoints New Auditor
Ticker: VVOS · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1716166
| Field | Detail |
|---|---|
| Company | Vivos Therapeutics, Inc. (VVOS) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Vivos Therapeutics swapped auditors, moving from BDO USA to CohnReznick LLP, effective June 3rd.
AI Summary
Vivos Therapeutics, Inc. announced on June 6, 2025, that it has appointed a new independent registered public accounting firm, CohnReznick LLP, effective June 3, 2025. This change follows the resignation of their previous auditor, BDO USA, P.A. The company stated there were no disagreements with BDO USA, P.A. on any matter of accounting principles or practices or financial statement disclosure.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors will monitor.
Risk Assessment
Risk Level: low — This filing is a routine change of auditor and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- Vivos Therapeutics, Inc. (company) — Registrant
- CohnReznick LLP (company) — New independent registered public accounting firm
- BDO USA, P.A. (company) — Former independent registered public accounting firm
- June 6, 2025 (date) — Date of report
- June 3, 2025 (date) — Effective date of auditor change
FAQ
Who is Vivos Therapeutics, Inc.'s new independent registered public accounting firm?
Vivos Therapeutics, Inc.'s new independent registered public accounting firm is CohnReznick LLP.
When did the change in auditor become effective?
The change in auditor became effective on June 3, 2025.
Who was Vivos Therapeutics, Inc.'s previous independent registered public accounting firm?
Vivos Therapeutics, Inc.'s previous independent registered public accounting firm was BDO USA, P.A.
Were there any disagreements with the former auditor, BDO USA, P.A.?
No, Vivos Therapeutics, Inc. stated there were no disagreements with BDO USA, P.A. on any matter of accounting principles or practices or financial statement disclosure.
What is the filing date of this Form 8-K?
The filing date of this Form 8-K is June 6, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Vivos Therapeutics, Inc. (VVOS).